TrialJournal of neuro-oncology2013

Prospective evaluation of health-related quality of life in patients with glioblastoma multiforme treated on a phase II trial of hypofractionated IMRT with temozolomide.

Krishna Reddy et al.PubMed ↗Publisher ↗

No numbers read from the abstract.